Koya, Y., Nara, H., Yagi, S., Ueno, C., & Kamohara, M. (2021). An engineered tetra-valent antibody fully activates the Tie2 receptor with comparable potency to its natural ligand angiopoietin-1. Nature Portfolio.
Cita Chicago Style (17a ed.)Koya, Yukari, Hiromi Nara, Shigenori Yagi, Chihoko Ueno, y Masazumi Kamohara. An Engineered Tetra-valent Antibody Fully Activates the Tie2 Receptor with Comparable Potency to Its Natural Ligand Angiopoietin-1. Nature Portfolio, 2021.
Cita MLA (8a ed.)Koya, Yukari, et al. An Engineered Tetra-valent Antibody Fully Activates the Tie2 Receptor with Comparable Potency to Its Natural Ligand Angiopoietin-1. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.